Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients [version 3; peer review: 1 approved, 1 approved with reservations]

Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon...

Full description

Saved in:
Bibliographic Details
Published inF1000 research Vol. 11; p. 148
Main Authors Dwianingsih, Ery Kus, Iskandar, Kristy, Hapsara, Sunartini, Ping Liu, Chun, Malueka, Rusdy Ghazali, Gunadi, ., Matsuo, Masafumi, Lai, Poh San
Format Journal Article
LanguageEnglish
Published England Faculty of 1000 Ltd 2022
F1000 Research Ltd
Subjects
Age
Becker muscular dystrophy
Becker's muscular dystrophy
Biopsy
Cross-Sectional Studies
Developing countries
DMD gene
Duchenne muscular dystrophy
Duchenne's muscular dystrophy
Dystrophin
Dystrophin - genetics
eng
Exon skipping
Feasibility studies
Gait
Gene Deletion
Genetic testing
Genotypes
Humans
Indonesia
Kinases
LDCs
Male
MLPA
Muscular dystrophy
Muscular Dystrophy, Duchenne - genetics
Mutation
Mutation - genetics
mutation analysis
Proteins
Scoliosis
Software
Spectrum analysis
Stop codon
Walking
Indonesia
United States > US
Becker muscular dystrophy
MLPA
Duchenne muscular dystrophy
DMD gene
mutation analysis
Indonesia
Online AccessGet full text

Cover

Abstract Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies. Methods This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene. Results Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy. Conclusion This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
AbstractList Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies. Methods This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene. Results Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy. Conclusion This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies. Methods This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene. Results Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy. Conclusion This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies. Methods This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene. Results Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy. Conclusion This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies.MethodsThis study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene.ResultsOut of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy.ConclusionThis is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the gene. The full mutation spectrum of the gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the gene in Indonesia to guide future development and application of feasible therapeutic strategies. This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the gene. Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy. This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of cases in the country.
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies.BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies.This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene.MethodsThis study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene.Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy.ResultsOut of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy.This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.ConclusionThis is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
Author Lai, Poh San
Dwianingsih, Ery Kus
Iskandar, Kristy
Hapsara, Sunartini
Malueka, Rusdy Ghazali
Ping Liu, Chun
Gunadi, .
Matsuo, Masafumi
Author_xml – sequence: 1
  givenname: Ery Kus
  orcidid: 0000-0002-0484-7773
  surname: Dwianingsih
  fullname: Dwianingsih, Ery Kus
  organization: Department of Anatomical Pathology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
– sequence: 2
  givenname: Kristy
  surname: Iskandar
  fullname: Iskandar, Kristy
  organization: Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
– sequence: 3
  givenname: Sunartini
  surname: Hapsara
  fullname: Hapsara, Sunartini
  organization: Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
– sequence: 4
  givenname: Chun
  surname: Ping Liu
  fullname: Ping Liu, Chun
  organization: Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore
– sequence: 5
  givenname: Rusdy Ghazali
  surname: Malueka
  fullname: Malueka, Rusdy Ghazali
  organization: Department of Neurology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
– sequence: 6
  givenname: .
  surname: Gunadi
  fullname: Gunadi, .
  organization: Pediatric Surgery Division, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia
– sequence: 7
  givenname: Masafumi
  surname: Matsuo
  fullname: Matsuo, Masafumi
  organization: KNC Department of Nucleic Acid Drug Discovery, Faculty of Rehabilitation, Kobegakuin University, Kobe, 651-2180, Japan
– sequence: 8
  givenname: Poh San
  orcidid: 0000-0003-3352-2000
  surname: Lai
  fullname: Lai, Poh San
  email: paelaips@nus.edu.sg
  organization: Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38009102$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1vEzEQhi1UREvoX6gsceFAgr_W3i0naPiI1IoLnBCyHHu22bBrb-3dVPlF_E2cpESFCyePR8-8nvE7z9GJDx4QuqBkRpksyzc1JYRESGCiXc0UF0rO-BN0xoiQUyoIO3kUn6LzlNa5gFQVl0w9Q6e8zBdK2Bn6dTMOZmiCx6kHO8Sxw8abdpuahEON5zdzfAsecOPxwrvcRmqMx_PRrsDntPEOvwf7EyLuxmTH1kTstmmIoV9tcZ-VwQ8Jf99ATLtH-FvcQ4YjbBq4v8QUm76PYQPu9aMY3zfDCu_mi5t9c-nHC_S0Nm2C84dzgr59_PD16vP0-sunxdW766nlUvIpq11RSFqKUvESbF1JYlxV5_9SUC4ZWGeEWMoiX01Zq5oo5hgI65ijikvgE7Q46Lpg1rqPTWfiVgfT6H0ixFtt4tDYFnThlCqBO1BqKYSozFIUvCKEWUupVDJrvTpo5anuRkiD7ppkoW2NhzAmzcpKcEmL3OsEvfwHXYcxZiP2lNxZR6tMXTxQ47IDd2zvj50ZkAfAxpBShPqIUKL3q6P_Wh29Xx3Nc-HlobA22cRhu4P0kfpP8W-clMwg
Cites_doi 10.1152/jn.00248.2016
10.1002/mus.20586
10.3390/molecules201018168
10.4103/0971-6866.96667
10.1016/0092-8674(91)90035-W
10.1371/journal.pntd.0006932
10.1016/0888-7543(88)90113-9
10.1007/s100380200084
10.1002/jcla.21787
10.1212/NXG.0000000000000536
10.1016/j.jpeds.2014.07.006
10.1186/s13104-019-4730-1
10.1161/CIRCGEN.117.001782
10.1371/journal.pone.0135189
10.1016/j.nmd.2006.01.004
10.1016/j.nmd.2010.03.007
10.1016/j.pjnns.2014.10.004
10.3109/09638288.2015.1111434
10.14238/pi59.5.2019.257-64
10.1002/humu.21114
10.1038/jhg.2014.36
10.1038/jhg.2013.119
10.1186/s13023-017-0703-4
10.1016/j.nmd.2017.06.007
10.1016/S0960-8966(99)00116-9
10.1177/0883073810371004
10.1136/jcp.54.7.517
10.1016/j.nmd.2016.09.008
10.1038/jhg.2010.49
10.3390/jcm8050649
10.1007/s00415-019-09380-3
10.1007/s10048-004-0204-1
10.2147/AHMT.S125739
10.1038/jhg.2015.43
10.3109/01677063.2012.762580
10.1093/nar/gnf056
10.1016/j.cca.2014.05.018
10.6084/m9.figshare.15172167.v2
10.1371/journal.pone.0197205
10.1111/j.1399-0004.2009.01173.x
10.1002/ajmg.c.31704
10.3109/01677063.2013.830616
ContentType Journal Article
Copyright Copyright: © 2023 Dwianingsih EK et al.
Copyright: © 2023 Dwianingsih EK et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2023 Dwianingsih EK et al.
– notice: Copyright: © 2023 Dwianingsih EK et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C-E
CH4
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.12688/f1000research.73476.3
DatabaseName F1000Research
Faculty of 1000
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef


Publicly Available Content Database
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Women's Studies
EISSN 2046-1402
ExternalDocumentID oai_doaj_org_article_5d778e3de77b4449ab4539002cc11676
38009102
10_12688_f1000research_73476_3
Genre Journal Article
GeographicLocations Indonesia
United States--US
GeographicLocations_xml – name: Indonesia
– name: United States--US
GrantInformation_xml – fundername: NUS-UGM-Tahir Foundation grant
GroupedDBID 3V.
53G
5VS
7X7
88I
8FE
8FH
8FI
8FJ
AAFWJ
ABUWG
ACGOD
ACPRK
ADBBV
ADRAZ
AFKRA
AFPKN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C-E
CCPQU
CH4
DIK
DWQXO
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HYE
KQ8
LK8
M2P
M48
M7P
M~E
OK1
PIMPY
PQQKQ
PROAC
RPM
UKHRP
W2D
AAYXX
ALIPV
CITATION
HMCUK
PGMZT
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c3663-2fd5561848738ecf960ad9ff107e8b2ecda44b6507ea8f7f072d2e4cd2d1736e3
IEDL.DBID M48
ISSN 2046-1402
IngestDate Wed Aug 27 01:24:30 EDT 2025
Fri Jul 11 01:00:51 EDT 2025
Fri Jul 25 10:19:58 EDT 2025
Thu Jan 02 22:41:03 EST 2025
Tue Jul 01 04:28:10 EDT 2025
Sat Nov 18 01:10:07 EST 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Becker muscular dystrophy
MLPA
Duchenne muscular dystrophy
DMD gene
mutation analysis
Indonesia
Language English
License http://creativecommons.org/licenses/by/4.0/: This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright: © 2023 Dwianingsih EK et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3663-2fd5561848738ecf960ad9ff107e8b2ecda44b6507ea8f7f072d2e4cd2d1736e3
Notes new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0484-7773
0000-0003-3352-2000
0000-0002-4707-6526
0000-0001-6835-0638
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.12688/f1000research.73476.3
PMID 38009102
PQID 2896009919
PQPubID 2045578
ParticipantIDs doaj_primary_oai_doaj_org_article_5d778e3de77b4449ab4539002cc11676
proquest_miscellaneous_2894361587
proquest_journals_2896009919
pubmed_primary_38009102
crossref_primary_10_12688_f1000research_73476_3
faculty1000_research_10_12688_f1000research_73476_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle F1000 research
PublicationTitleAlternate F1000Res
PublicationYear 2022
Publisher Faculty of 1000 Ltd
F1000 Research Ltd
Publisher_xml – name: Faculty of 1000 Ltd
– name: F1000 Research Ltd
References P Lai (ref17) 2002; 47
M Falzarano (ref33) 2015; 20
A Monaco (ref3) 1988; 2
L Passamano (ref37) 2012; 31
S Tomar (ref8) 2019; 181
L Bogue (ref48) 2016; 26
S Wedhanto (ref5) 2007; 57
F Mohammed (ref29) 2018; 13
S Sun (ref10) 2008; 10
M Okubo (ref6) 2017; 12
B Janssen (ref31) 2005; 6
M Rae (ref43) 2016; 116
E Dwianingsih (ref18) 2019; 59
T Lee (ref44) 2014; 59
J Andrews (ref35) 2018; 9
E Dwianingsih (ref15) 2014; 59
J Zimowski (ref25) 2014; 48
E Niba (ref34) 2014; 436
R Guo (ref20) 2015; 60
A Aartsma-Rus (ref32) 2006; 34
S Sakthivel Murugan (ref45) 2013; 137
J Schouten (ref7) 2002; 30
J Ervasti (ref2) 1991; 66
T Yamamoto (ref38) 2018; 11
M Toussaint (ref40) 2016; 38
S Murugan (ref21) 2010; 132
V Arechavala-Gomeza (ref12) 2010; 20
S Hoshino (ref16) 2000; 10
K Polavarapu (ref27) 2019; 266
L Thanh (ref13) 1995; 56
L Bello (ref14) 2019; 8
K Iskandar (ref19) 2019; 12
Y Takeshima (ref1) 2010; 55
R Moxley (ref36) 2010; 25
X Ji (ref26) 2015; 29
R Selvatici (ref30) 2021; 7
M Matsumoto (ref41) 2017; 27
K Mirski (ref42) 2014; 165
C Tam (ref4) 2018; 12
E Dwianingsih (ref9) 2021
K Flanigan (ref28) 2009; 30
I Sheriffs (ref11) 2001; 54
A Rani (ref23) 2013; 27
A Helderman-van den Enden (ref46) 2009; 75
V Tran (ref22) 2013; 27
P Verma (ref47) 2012; 18
J Juan-Mateu (ref24) 2015; 10
F Muntoni (ref39) 2006; 16
References_xml – volume: 116
  start-page: 1304-1315
  year: 2016
  ident: ref43
  article-title: Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.
  publication-title: J. Neurophysiol.
  doi: 10.1152/jn.00248.2016
– volume: 34
  start-page: 135-144
  year: 2006
  ident: ref32
  article-title: Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.
  publication-title: Muscle Nerve.
  doi: 10.1002/mus.20586
– volume: 20
  start-page: 18168-18184
  year: 2015
  ident: ref33
  article-title: Duchenne muscular dystrophy: from diagnosis to therapy.
  publication-title: Molecules.
  doi: 10.3390/molecules201018168
– volume: 18
  start-page: 91-94
  year: 2012
  ident: ref47
  article-title: Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy.
  publication-title: Indian J. Hum. Genet.
  doi: 10.4103/0971-6866.96667
– volume: 66
  start-page: 1121-1131
  year: 1991
  ident: ref2
  article-title: Membrane organization of the dystrophin-glycoprotein complex.
  publication-title: Cell.
  doi: 10.1016/0092-8674(91)90035-W
– volume: 12
  start-page: e0006932
  year: 2018
  ident: ref4
  article-title: Geographic variation in dengue seroprevalence and force of infection in the urban paediatric population of Indonesia.
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0006932
– volume: 2
  start-page: 90-95
  year: 1988
  ident: ref3
  article-title: An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
  publication-title: Genomics.
  doi: 10.1016/0888-7543(88)90113-9
– volume: 47
  start-page: 0552-0555
  year: 2002
  ident: ref17
  article-title: Comparative study on deletions of the dystrophin gene in three Asian populations.
  publication-title: J. Hum. Genet.
  doi: 10.1007/s100380200084
– volume: 31
  start-page: 121-125
  year: 2012
  ident: ref37
  article-title: Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.
  publication-title: Acta Myol.
– volume: 29
  start-page: 405-411
  year: 2015
  ident: ref26
  article-title: MLPA application in clinical diagnosis of DMD/BMD in Shanghai.
  publication-title: J. Clin. Lab. Anal.
  doi: 10.1002/jcla.21787
– volume: 7
  start-page: e536
  year: 2021
  ident: ref30
  article-title: Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries.
  publication-title: Neurol Genet.
  doi: 10.1212/NXG.0000000000000536
– volume: 165
  start-page: 1008-1010
  year: 2014
  ident: ref42
  article-title: Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosis.
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2014.07.006
– volume: 12
  start-page: 704
  year: 2019
  ident: ref19
  article-title: The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine.
  publication-title: BMC. Res. Notes.
  doi: 10.1186/s13104-019-4730-1
– volume: 11
  start-page: e001782
  year: 2018
  ident: ref38
  article-title: Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.
  publication-title: Circ. Genom. Precis. Med.
  doi: 10.1161/CIRCGEN.117.001782
– volume: 10
  start-page: e0135189
  year: 2015
  ident: ref24
  article-title: DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0135189
– volume: 16
  start-page: 210-219
  year: 2006
  ident: ref39
  article-title: Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London.
  publication-title: UK. Neuromuscul. Disord.
  doi: 10.1016/j.nmd.2006.01.004
– volume: 132
  start-page: 303-311
  year: 2010
  ident: ref21
  article-title: Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.
  publication-title: Indian J. Med. Res.
– volume: 20
  start-page: 295-301
  year: 2010
  ident: ref12
  article-title: Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.
  publication-title: Neuromuscul. Disord.
  doi: 10.1016/j.nmd.2010.03.007
– volume: 48
  start-page: 416-422
  year: 2014
  ident: ref25
  article-title: MLPA based detection of mutations in the dystrophin gene of 180 Polish families with Duchenne/Becker muscular dystrophy.
  publication-title: Neurol. Neurochir. Pol.
  doi: 10.1016/j.pjnns.2014.10.004
– volume: 38
  start-page: 2052-2062
  year: 2016
  ident: ref40
  article-title: Dysphagia in Duchenne muscular dystrophy: practical recommendations to guide management.
  publication-title: Disabil. Rehabil.
  doi: 10.3109/09638288.2015.1111434
– volume: 59
  start-page: 257-264
  year: 2019
  ident: ref18
  article-title: Clinicopathologic and molecular profiles of Duchenne and Becker muscular dystrophy.
  publication-title: Paediatr. Indones.
  doi: 10.14238/pi59.5.2019.257-64
– volume: 30
  start-page: 1657-1666
  year: 2009
  ident: ref28
  article-title: Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.
  publication-title: Hum. Mutat.
  doi: 10.1002/humu.21114
– volume: 59
  start-page: 423-429
  year: 2014
  ident: ref15
  article-title: A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.
  publication-title: J. Hum. Genet.
  doi: 10.1038/jhg.2014.36
– volume: 59
  start-page: 46-50
  year: 2014
  ident: ref44
  article-title: Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients.
  publication-title: J. Hum. Genet.
  doi: 10.1038/jhg.2013.119
– volume: 12
  start-page: 149
  year: 2017
  ident: ref6
  article-title: Comprehensive analysis for genetic diagnosis of dystrophinopathies in Japan.
  publication-title: Orphanet J. Rare Dis.
  doi: 10.1186/s13023-017-0703-4
– volume: 27
  start-page: 1023-1028
  year: 2017
  ident: ref41
  article-title: Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
  publication-title: Neuromuscul. Disord.
  doi: 10.1016/j.nmd.2017.06.007
– volume: 10
  start-page: 425-429
  year: 2000
  ident: ref16
  article-title: Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
  publication-title: Neuromuscul. Disord.
  doi: 10.1016/S0960-8966(99)00116-9
– volume: 25
  start-page: 1116-1129
  year: 2010
  ident: ref36
  article-title: Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.
  publication-title: J. Child Neurol.
  doi: 10.1177/0883073810371004
– volume: 57
  start-page: 312
  year: 2007
  ident: ref5
  article-title: Duchenne muscular dystrophy.
  publication-title: Majalah Kedokteran Indonesia.
– volume: 54
  start-page: 517-520
  year: 2001
  ident: ref11
  article-title: Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy.
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jcp.54.7.517
– volume: 26
  start-page: 860-864
  year: 2016
  ident: ref48
  article-title: Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.
  publication-title: Neuromuscul. Disord.
  doi: 10.1016/j.nmd.2016.09.008
– volume: 55
  start-page: 379-388
  year: 2010
  ident: ref1
  article-title: Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.
  publication-title: J. Hum. Genet.
  doi: 10.1038/jhg.2010.49
– volume: 8
  year: 2019
  ident: ref14
  article-title: The “Usual Suspects”: Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy.
  publication-title: J. Clin. Med.
  doi: 10.3390/jcm8050649
– volume: 266
  start-page: 2177-2185
  year: 2019
  ident: ref27
  article-title: Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort.
  publication-title: J. Neurol.
  doi: 10.1007/s00415-019-09380-3
– volume: 137
  start-page: 1102-1110
  year: 2013
  ident: ref45
  article-title: Carrier detection in Duchenne muscular dystrophy using molecular methods.
  publication-title: Indian J. Med. Res.
– volume: 6
  start-page: 29-35
  year: 2005
  ident: ref31
  article-title: MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls.
  publication-title: Neurogenetics.
  doi: 10.1007/s10048-004-0204-1
– volume: 9
  start-page: 53-63
  year: 2018
  ident: ref35
  article-title: Duchenne and Becker muscular dystrophy in adolescents: current perspectives.
  publication-title: Adolesc. Health Med. Ther.
  doi: 10.2147/AHMT.S125739
– volume: 10
  start-page: 35-37
  year: 2008
  ident: ref10
  article-title: Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy.
  publication-title: Zhongguo Dang Dai Er Ke Za Zhi.
– volume: 56
  start-page: 725-731
  year: 1995
  ident: ref13
  article-title: Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.
  publication-title: Am. J. Hum. Genet.
– volume: 60
  start-page: 435-442
  year: 2015
  ident: ref20
  article-title: DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy.
  publication-title: J. Hum. Genet.
  doi: 10.1038/jhg.2015.43
– volume: 27
  start-page: 11-15
  year: 2013
  ident: ref23
  article-title: Mutation spectrum of dystrophin gene in malaysian patients with Duchenne/Becker muscular dystrophy.
  publication-title: J. Neurogenet.
  doi: 10.3109/01677063.2012.762580
– volume: 30
  start-page: 57e-557e
  year: 2002
  ident: ref7
  article-title: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gnf056
– volume: 436
  start-page: 155-159
  year: 2014
  ident: ref34
  article-title: Validation of ambiguous MLPA results by targeted next-generationsequencing discloses a nonsense mutation in the DMD gene.
  publication-title: Clin. Chim. Acta.
  doi: 10.1016/j.cca.2014.05.018
– year: 2021
  ident: ref9
  article-title: Mutation Spectrum Analysis of DMD gene using MLPA method in Indonesian Duchenne and Becker muscular dystrophy patients. figshare. Dataset.
  doi: 10.6084/m9.figshare.15172167.v2
– volume: 13
  start-page: e0197205
  year: 2018
  ident: ref29
  article-title: Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: The era of personalized medicine.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0197205
– volume: 75
  start-page: 465-472
  year: 2009
  ident: ref46
  article-title: Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy.
  publication-title: Clin. Genet.
  doi: 10.1111/j.1399-0004.2009.01173.x
– volume: 181
  start-page: 230-244
  year: 2019
  ident: ref8
  article-title: Mutational spectrum of dystrophinopathies in Singapore: Insights for genetic diagnosis and precision therapy.
  publication-title: Am. J. Med. Genet. C Semin. Med. Genet.
  doi: 10.1002/ajmg.c.31704
– volume: 27
  start-page: 170-175
  year: 2013
  ident: ref22
  article-title: Exon deletion patterns of the dystrophin gene in 82 Vietnamese Duchenne/Becker muscular dystrophy patients.
  publication-title: J. Neurogenet.
  doi: 10.3109/01677063.2013.830616
SSID ssj0000993627
Score 2.212872
Snippet Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation...
Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation...
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the gene. The full mutation spectrum of the...
BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation...
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of...
Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation...
SourceID doaj
proquest
pubmed
crossref
faculty1000
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 148
SubjectTerms Age
Becker muscular dystrophy
Becker's muscular dystrophy
Biopsy
Cross-Sectional Studies
Developing countries
DMD gene
Duchenne muscular dystrophy
Duchenne's muscular dystrophy
Dystrophin
Dystrophin - genetics
eng
Exon skipping
Feasibility studies
Gait
Gene Deletion
Genetic testing
Genotypes
Humans
Indonesia
Kinases
LDCs
Male
MLPA
Muscular dystrophy
Muscular Dystrophy, Duchenne - genetics
Mutation
Mutation - genetics
mutation analysis
Proteins
Scoliosis
Software
Spectrum analysis
Stop codon
Walking
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5KDqU5hDZ9uU3DFAo9bbKRZEtuT003IS1sTw0EShG2HqSF7IZsHMhP6L_ujKQsm0PIJRcf7AHLmpH1jWbmG4APnvSsXMMRRlfThTBcJ2ozklHT5hVj3_YpQfZHc3Ssvp_UJyutvjgnLNMD54nbrb3WJkgftO6VUm3Xq5r89LFwjkMIiWyb9rwVZ-pvxj30Z9alJFg05OZFPskuDDqnO1oq3ezIW7tRIu1fh_XYMevFNcvfjTvT_nP4FDYKcMQvecDP4FGYbcLjaQmNb8JG6kX5cYElM_A5_JsOOc6OqZzyYjjDrlCQ4DziZDpBsp6Af2b4jXt6BK6nxMlAaqSfL8l63A-cdYFnQ05XRX-9uLyYk2aw8LEu8NdVPnFD-RnPAwnnYphPKDDxlV8F__sFHB8e_Px6NCqdF0ZOEgQZiei5baYhb0aa4CK5OZ1vI02hDqYXwflOqZ7AnQ6diTqOtfAiKOeF39OyCfIlrM1o3K8Bmd_Ii1gL1bcq1uS7p9Ct8WPlnTG-gt0bDdjzTLBh2TFhndlbOrNJZ1ZWsM-KWkozQXa6QWZji9nY-8ymArmiZrt8x32v3roxB1vW-sKSy9qwwe21FbxfPqZVyqGXbhbmQ5JRksCj0RW8yma0HL8kzE6gTbx5iO96C08EF2ikQ6ItWCPjCu8INl3222mF_AdrUhFO
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT9wwEB5RkKpyQJS2kBYqV0LqKTxsJ3ZOFbAgWml7AmlvVuJH4cAGNuTAv--M403Lgfayh93RJvI3Hn_z8AzAvkOcpS0pw2gL_EAOV_NC5yIoPLxCaKomFsj-LC-v5Y9ZMUsBty6VVS5tYjTUrrUUIz9Ex6AkOnNcfbt_yGlqFGVX0wiNV7BGrcuopEvN1BhjQXG0zypdDOYlOnuB4tmpj87NgRJSlQfi2ZkUW_evw3qoqffFE8m_zD7jKXSxCRuJPrKTAe-3sOLnW_B6mhLkW7ARJ1J-7ViqD3wHbtoP2XYWL1Uu-jtWp0YkrA1sMp0w1CHPbufsO0328HSrkk16BBNNMMo6duqp9oLd9UPRKnNP3eOiRXxY6sravYfri_Ors8s8jVbIrUCOkfPgaC6mRndFaG8Drm3tqoCro7xuuLeulrJB9qZ8rYMKR4o77qV13B0rUXrxAVbn-Eo7wKiBkeOh4LKpZCjQOY-5We2OpLNauwwOl4tr7ocOGoY8D4LDPIPDRDiMyOCUMBilqQN2_KJd_DJpQ5nCKaW9cF6pRkpZ1Y0sRIX23VpKLZUZiL8QNOMz_vfo3SXSJm3mzvxRvQy-jD_jNqTcSj33bR9lpEB2qFUG24OGjO8vkJQjK-Mf__3nn-ANp7sVMb6zC6uoEX4PGc9j8zmq9W_c7fy0
  priority: 102
  providerName: ProQuest
Title Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients [version 3; peer review: 1 approved, 1 approved with reservations]
URI http://dx.doi.org/10.12688/f1000research.73476.3
https://www.ncbi.nlm.nih.gov/pubmed/38009102
https://www.proquest.com/docview/2896009919
https://www.proquest.com/docview/2894361587
https://doaj.org/article/5d778e3de77b4449ab4539002cc11676
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9RAEB76AmI_FK1v0XqMIPjFO3vZTXajiHheaxWuiHhwICUk2V1fsHf10hTvF_k3ndnsHS1YBL-EIzchyc5M5pmZnRmAx4b4LKuUM4xVQgfCcEWc6K5wioyXc2VW-g2yR-nhWL6fJJM1WI5LDQtY_9W143lS4_mP3q-fi1ek8C99b4SUPDjHQerQHOdrTwmp0p5Yh02yToqVdRQg__cWEdE3W4Vi4asvv2SnfDv_LdhyBffDWDD91YjUW6aDG7AdICW-bmXgJqzZ6Q5cG4Wk-Q5s-ymVT2oMewZvwe9R02bg0RdazpsTLEJzEpw5HI6GSHJl8dsU3_G0D8uVljhsiMH0WSZagwPL-zHwpGk3sqJZ1GfzGfEMQ6fWGj-ft7E4FC_w1BJxWybzHPvoO5mfW_P0wm_kkDDyAoUwcX18G8YH-5_eHHbDxIZuJQi6dGNneNymJi9IaFs5co8KkzlaYGV1GdvKFFKWBAqVLbRTbk_FJrayMrHpK5FacQc2pvRW9wC5L5KJXRLLMpMuIZ_fp3y12ZOm0tpE8GzJn_y0bcyRs0PDHM0vcTT3HM1FBANm44qaG2v7E7P5lzzoaZ4YpbQVxipVSimzopSJyMhsVBVnrNIIxAUhyFf3-Netd5fCki9FPCdXN2Vx7GcRPFr9TdrNKZtiameNp5GCQKdWEdxthWz1_IKwPoG9-P5_PdIDuB5zJYePJu3CBsmafUj46qzswLqaqA5sDvaPPnzs-CgFHd9O-h2vSn8AETsl0Q
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFH8anQTsMMH4KgwwEohTttV24uSAEKWbWrZWCG3Sbibxx8ZhzWhWof5T_I2857iFHYDTLjkklmP5_ez3_R7Aa4t0liYjD6NJ8YEyXMnTPBFeIfPyviqqECA7yYYn8tNperoGP5e5MBRWubwTw0Vta0M28l1UDDISZ3rF-8vvCXWNIu_qsoVGC4tDt_iBKlvzbjRA-r7h_GD_-OMwiV0FEiOQvSbcW2oJmaOkLnJnPE5b2sJ71INcXnFnbCllhYKLcmXuld9T3HInjeW2p0TmBM57C9alQFWmA-v9_cnnLyurDi4QOYKKqcg8Q_XSkwU9Vu4531FCqmxHXOOCoVnABmz4kqptLGj83-XdwPcO7sFmFFjZhxZh92HNTbfg9ji65LdgM_TAfNuwGJH4AOx43vr3WUjjnM0vWBlLn7Das8F4wBC1jn2bshH1EnGUx8kGc4QPXvo41rK-o2gPdjFvw2SZXTRXsxoRwWId2OYhnNzItj-CzhSX9AQYlUyy3KdcVoX0qatE8Abndk9ak-e2C7vLzdWXbc0OTboOkUNfI4cO5NCiC32iwWo01dwOL-rZmY5HWKdWqdwJ65SqpJRFWclUFMhRjCFnVtYF8QcF9eof__v19pLSOl4fjf4N9i68Wn3Gg0_enHLq6nkYgxjspbnqwuMWIav1C1QDUA7kT_89-Uu4MzweH-mj0eTwGdzllNkRrEvb0EF0uOcob11VLyLIGXy96XP1C4MdOzI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlX0UEGBEihgJBCndLu2EycHhChh1aVsxYFKezNJbAOHbspuI7SvxtMx4ziBHoBTLzkkVmx5xjPfeP4Anhuks6xT8jDWCT4Qw5U8yWLhFCov56q88gGyp-nxmXw_T-Yb8LPPhaGwyl4mekFtmpruyEdoGKQEZ8b5yIWwiI_F5PXF95g6SJGntW-n0bHIiV3_QPNt9WpaIK1fcD559-ntcRw6DMS1QFUbc2eoPWSGqF1ktnY4RWly59AmslnFbW1KKSsEMcqWmVPuUHHDrawNN2MlUivwvzfgphLJmM6YmqvhfgeXirpBhaRknqKh6eguPdTw-XqghFTpgbiiD33bgG3YdiXV3VjT-L8jX68BJ7dhJ0BX9qbjtTuwYRe7sDULzvld2PHdMF-uWIhNvAtm1naefuYTOpftOStDERTWOFbMCob8a9m3BZtSVxFLGZ2saJGRUPzjWMOOLMV9sPO2C5hlZr26XDbIGyxUhF3dg7Nr2fT7sLnAJT0ARsWTDHcJl1UuXWIr4f3CmTmUps4yE8Go31x90VXv0GT1EDn0FXJoTw4tIjgiGgyjqfq2f9Esv-hwmHVilMqsMFapSkqZl5VMRI66pa7JrZVGIP6goB7m-N_U-z2ldRAkK_2b7SN4NnxGEUB-nXJhm9aPkQKRaaYi2Os4ZFi_QIMAESF_-O-fP4UtPE36w_T05BHc4pTi4a-Z9mETmcM-RuB1WT3xHM7g83UfqV_NZT4C
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mutation+spectrum+analysis+of+DMD+gene+in+Indonesian+Duchenne+and+Becker+muscular+dystrophy+patients+%5Bversion+3%3B+peer+review%3A+1+approved%2C+1+approved+with+reservations%5D&rft.jtitle=F1000+research&rft.au=Dwianingsih%2C+Ery+Kus&rft.au=Iskandar%2C+Kristy&rft.au=Hapsara%2C+Sunartini&rft.au=Ping+Liu%2C+Chun&rft.date=2022&rft.eissn=2046-1402&rft.volume=11&rft_id=info:doi/10.12688%2Ff1000research.73476.3&rft.externalDBID=C-E&rft.externalDocID=10_12688_f1000research_73476_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-1402&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-1402&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-1402&client=summon